Posted Jul. 27, 2012 at 11:23 a.m.

Premium Lock Cornerstone's new drug looks to treat Hyponatremia

Published: 2012-07-27 11:23:31
Updated: 2012-07-27 11:23:31

Cornerstone Therapeutics

The FDA will soon review the company's new drug application for lixivaptan which aims to curb electrolyte disorders....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders